Jordan

BMI View: We believe despite a temporary cash flow crisis for private hospitals in Jordan they will still have profited greatly from the influx of Libyan patients. It is our view that... 2012-03-22

BMI View: Though Jordan's pharmaceutical exports were poor in 2011, they should return to growth in 2012 as stability returns to the region and loose fiscal policy drives government... 2012-03-02

BMI Core View: Political stability, a cost-effective healthcare system and an established tourism sector are the fundamental prerequisites for developing a medical tourism industry.... 2012-02-09

BMI View: Despite the revenue restricting effects of the Arab Spring, the prospects of a second global recession and the Eurozone sovereign debt crisis, BMI believes Hikma Pharmaceuticals'... 2011-10-07

BMI View: Despite the revenue restricting effects of the Arab Spring, the prospects of a second global recession and the Eurozone sovereign debt crisis, BMI believes Hikma Pharmaceuticals'... 2011-10-07

BMI View: We believe that complying with international intellectual property (IP) law has been a boon for Jordan's domestic pharmaceutical sector and pharmaceutical exports. It is no... 2011-08-19

BMI View: Jordan's dramatic loss of medical tourists since the start of the Middle East and North Africa (MENA) crisis could help private healthcare providers in the more stable states... 2011-06-16

Furthermore, we note that while Hikma is heavily exposed to the unrest in the MENA region, the company is attempting to increase its presence in the US and diversify its portfolio to... 2011-03-21

BMI View: While a plunge in Hikma Pharmaceuticals' share price has shown developments across Tunisia, Egypt, Libya and other markets in the Middle East and North Africa (MENA) region... 2011-03-02

BMI View: Jordan is a hub for pharmaceutical exports in the Middle East and has the strongest medical tourism sector in the region. There are investment opportunities in pharmaceutical... 2011-01-24